Literature DB >> 8493863

The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy.

D M Mann1, R Oliver, J S Snowden.   

Abstract

The topographic distribution of brain atrophy was quantified by image analysis of fixed coronal brain slices from 12 patients dying with Huntington's disease (HD) and from 4 other patients dying with progressive supranuclear palsy (PSP). In HD, atrophy was maximal within the caudate nucleus, putamen and globus pallidus. However, the cerebral cortex was also atrophied with reductions in cross-sectional area within frontal, temporal and parietal lobes. In general, more white matter than grey matter was lost leading to an elevation in the grey/white matter ratio. The amygdala and thalamus were reduced in area. In PSP, lesser reductions in cortical area than those of HD were seen, these again being mostly due to a loss of white matter, resulting in an elevation of the grey/white ratio. The globus pallidus and thalamus were decreased in area, but no changes in the caudate nucleus and putamen were measured.

Entities:  

Mesh:

Year:  1993        PMID: 8493863     DOI: 10.1007/BF00230496

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  42 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

2.  The basal nucleus of Meynert in patients with progressive supranuclear palsy.

Authors:  F Tagliavini; G Pilleri; C Bouras; J Constantinidis
Journal:  Neurosci Lett       Date:  1984-01-27       Impact factor: 3.046

3.  A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques.

Authors:  D M Mann; A M Brown; D Prinja; D Jones; C A Davies
Journal:  Neuropathol Appl Neurobiol       Date:  1990-02       Impact factor: 8.090

4.  Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.

Authors:  T Arendt; V Bigl; A Arendt; A Tennstedt
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

5.  Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia.

Authors:  D Neary; J S Snowden; R A Shields; A W Burjan; B Northen; N MacDermott; M C Prescott; H J Testa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

6.  Dementia in Huntington's disease is associated with neurochemical deficits in the caudate nucleus, not the cerebral cortex.

Authors:  G P Reynolds; S J Pearson; K W Heathfield
Journal:  Neurosci Lett       Date:  1990-05-18       Impact factor: 3.046

7.  Progressive supranuclear palsy: clinico-pathological and biochemical studies.

Authors:  K Jellinger; P Riederer; M Tomonaga
Journal:  J Neural Transm Suppl       Date:  1980

8.  Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study.

Authors:  K A Bamford; E D Caine; D K Kido; W M Plassche; I Shoulson
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

9.  Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease.

Authors:  S M de la Monte; J P Vonsattel; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1988-09       Impact factor: 3.685

10.  Differential cognitive impairment in Alzheimer's disease and Huntington's disease.

Authors:  J Brandt; S E Folstein; M F Folstein
Journal:  Ann Neurol       Date:  1988-06       Impact factor: 10.422

View more
  35 in total

Review 1.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

2.  SPECT imaging of dopamine receptors with [123I]epidepride: characterization of uptake in the human brain.

Authors:  J Kornhuber; T Brücke; P Angelberger; S Asenbaum; I Podreka
Journal:  J Neural Transm Gen Sect       Date:  1995

3.  RTP801 Is Involved in Mutant Huntingtin-Induced Cell Death.

Authors:  Núria Martín-Flores; Joan Romaní-Aumedes; Laura Rué; Mercè Canal; Phil Sanders; Marco Straccia; Nicholas D Allen; Jordi Alberch; Josep M Canals; Esther Pérez-Navarro; Cristina Malagelada
Journal:  Mol Neurobiol       Date:  2015-04-16       Impact factor: 5.590

4.  Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.

Authors:  H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Vasanth Pappu; Bruce Fischl; Doug Greve; Nathanael Hevelone; Steven M Hersch
Journal:  Brain       Date:  2008-03-12       Impact factor: 13.501

5.  Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.

Authors:  Susie M D Henley; Edward J Wild; Nicola Z Hobbs; Rachael I Scahill; Gerard R Ridgway; David G Macmanus; Roger A Barker; Nick C Fox; Sarah J Tabrizi
Journal:  J Neurol       Date:  2009-03-05       Impact factor: 4.849

6.  Neuroanatomical Visualization of the Impaired Striatal Connectivity in Huntington's Disease Mouse Model.

Authors:  Dohee Kim; Jeha Jeon; Eunji Cheong; Dong Jin Kim; Hoon Ryu; Hyemyung Seo; Yun Kyung Kim
Journal:  Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.590

7.  Assessment of cortical and striatal involvement in 523 Huntington disease brains.

Authors:  Tiffany C Hadzi; Audrey E Hendricks; Jeanne C Latourelle; Kathryn L Lunetta; L Adrienne Cupples; Tammy Gillis; Jayalakshmi Srinidhi Mysore; James F Gusella; Marcy E MacDonald; Richard H Myers; Jean-Paul Vonsattel
Journal:  Neurology       Date:  2012-10-03       Impact factor: 9.910

8.  H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers.

Authors:  Elisa Canu; Marina Boccardi; Roberta Ghidoni; Luisa Benussi; Cristina Testa; Michela Pievani; Matteo Bonetti; Giuliano Binetti; Giovanni B Frisoni
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

9.  Irritability in pre-clinical Huntington's disease.

Authors:  Stefan Klöppel; Cynthia M Stonnington; Predrag Petrovic; Dean Mobbs; Oliver Tüscher; David Craufurd; Sarah J Tabrizi; Richard S J Frackowiak
Journal:  Neuropsychologia       Date:  2009-10-28       Impact factor: 3.139

10.  Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration.

Authors:  F Cicchetti; S Saporta; R A Hauser; M Parent; M Saint-Pierre; P R Sanberg; X J Li; J R Parker; Y Chu; E J Mufson; J H Kordower; T B Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.